Community Access Through Remote Eyesight (CARE) Study

Status Completed

Clinical Trial Summary

Study is a randomized clinical trial evaluating the efficacy of novel mobile application technologies (including Seeing AI, Aira, and Supervision+) to improve quality of life in older adults with low vision by expanding community access and providing assistance with activities of daily living. Aira provides real-time remote personal assistance through a sighted Aira agent supplying direct feedback to assist with visual tasks. Seeing AI provides optical character recognition allowing any text to be read aloud, color identification, bar code reading, scene description, and facial recognition based on stored photos. Supervision + allows one to use the phone as a magnifier, providing magnification and contrast enhancement using the camera of the mobile phone. This study seeks to understand the potential of these technologies to improve daily activities, community participation, independence, and self-sufficiency in this group by examining a technological approach, which has not yet undergone rigorous investigation in a diverse population of older adults with visual impairment. Project objectives are to evaluate mobile applications in a wide range of visual disability, categorized into three groups: (1) mild to moderate visual acuity loss, (2) severe to profound visual acuity loss, and (3) legal blindness secondary to visual field loss. Participants are randomized to one of three intervention groups: (1) Supervision+ application, (2) Aira application, or (3) Seeing AI application for a period of 6 months. For the Aira intervention group, participants will be assigned either with 'restricted' access (current open access areas plus 30 minutes/month anywhere), or 'unrestricted' access (700 minutes), for a period of 3 months with a 3 month cross-over period. Participants may elect to continue the study for an additional 3 months during which time they have access to all 3 study mobile applications. Outcome measures include assessment of changes at three, six and nine months post-intervention for: visual ability, health state (including depression), self-efficacy, loneliness, life space, distances travelled from the home, and types of services obtained.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04926974
Study type	Interventional
Source	New England College of Optometry
Contact
Status	Completed
Phase	N/A
Start date	June 2, 2021
Completion date	September 29, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04929756` - Eye Movement Rehabilitation in Low Vision Patients
Completed	`NCT04974307` - Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision	N/A
Completed	`NCT02310880` - Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World	N/A
Terminated	`NCT04040790` - Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris	N/A
Recruiting	`NCT06107881` - Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision	N/A
Completed	`NCT00545220` - Problem Solving Training and Low Vision Rehabilitation	N/A
Recruiting	`NCT04066075` - Beacon Sensors and Telerehabilitation for Low Vision	N/A
Recruiting	`NCT04281732` - Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Completed	`NCT01217502` - Self-management for Dual Sensory Impaired	N/A
Completed	`NCT00946062` - Evaluation of a Standardised Orientation and Mobility Training in Older Adults With Low Vision	N/A
Terminated	`NCT04276610` - Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning?	N/A
Recruiting	`NCT05829135` - Improving Glare and Visual Comfort for Patients With Visual Impairment	N/A
Completed	`NCT04242836` - Development and Validation of a Digital Optotype for Near Vision in Greek Language.
Terminated	`NCT03353727` - Orthoptic Rehabilitation for Low Vision People With Innovative Mechanisms (Eye Tracker and Tactile Device)	N/A
Completed	`NCT00348621` - A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents	Phase 4
Not yet recruiting	`NCT03104608` - Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD)	N/A
Completed	`NCT05491746` - Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study	N/A
Completed	`NCT03728660` - Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System	N/A
Completed	`NCT05209581` - Assessment of Visual Acuity in Refugee Population
Recruiting	`NCT01879501` - Living Successfully With Chronic Eye Diseases	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Community Access Through Remote Eyesight (CARE) Study — CARE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms